
DVAX
Healthcare · Drug Manufacturers - Specialty & Generic · $1.82B market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2025
EPS trend, 90 days to now · 30-day revisions 1 up, 0 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 13, 2026 | Time not confirmed | 0.08 | 0.00 | -100.0% |
| Feb 19, 2026 | Time not confirmed | 0.04 | 0.00 | -100.0% |
| Nov 5, 2025 | Time not confirmed | 0.13 | 0.21 | +61.5% |
| Aug 7, 2025 | Time not confirmed | 0.10 | 0.14 | +40.0% |
| May 6, 2025 | Before the open | 0.01 | -0.01 | -174.0% |
| Feb 20, 2025 | Before the open | 0.04 | 0.05 | +25.0% |
| Nov 7, 2024 | After the close | 0.11 | 0.12 | +9.1% |
| Aug 6, 2024 | After the close | 0.06 | 0.08 | +33.3% |
| May 8, 2024 | After the close | -0.02 | -0.07 | -250.0% |
| Feb 22, 2024 | After the close | -0.01 | 0.00 | +116.0% |
| Nov 2, 2023 | After the close | -0.01 | 0.10 | +1100.0% |
| Aug 3, 2023 | After the close | -0.09 | 0.03 | +133.3% |
| May 2, 2023 | After the close | -0.13 | -0.19 |
Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally. The company offers HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in adults aged 18 years and older; and CpG 1018, the adjuvant used in HEPLISAV-B. It also develops rF1V, a plague…
| -46.2% |
| Feb 23, 2023 | After the close | 0.43 | 0.45 | +4.7% |
| Nov 3, 2022 | After the close | 0.33 | 0.43 | +30.3% |
| Aug 4, 2022 | After the close | 0.22 | 0.87 | +295.5% |
| May 5, 2022 | After the close | 0.24 | 0.22 | -8.3% |
| Feb 28, 2022 | After the close | 0.64 | 0.55 | -14.1% |
| Nov 4, 2021 | After the close | 0.05 | -0.24 | -580.0% |
| Aug 4, 2021 | After the close | -0.04 | 0.02 | +150.0% |
| May 6, 2021 | After the close | -0.02 | 0.01 | +150.0% |
| Feb 25, 2021 | After the close | -0.24 | -0.14 | +41.7% |
| Nov 5, 2020 | After the close | -0.20 | -0.02 | +90.0% |
| Aug 6, 2020 | After the close | -0.24 | -0.53 | -120.8% |
| May 7, 2020 | After the close | -0.31 | -0.15 | +51.6% |
| Mar 11, 2020 | After the close | -0.33 | -0.44 | -33.3% |
| Nov 6, 2019 | After the close | -0.39 | -0.50 | -28.2% |
| Aug 7, 2019 | After the close | -0.56 | -0.52 | +7.1% |
| May 8, 2019 | After the close | -0.65 | -0.62 | +4.6% |
| Feb 26, 2019 | After the close | -0.61 | -0.64 | -4.9% |
| Nov 5, 2018 | After the close | -0.57 | -0.65 | -14.0% |
| Aug 6, 2018 | After the close | -0.63 | -0.63 | 0.0% |
| May 8, 2018 | After the close | -0.49 | -0.63 | -28.6% |
| Mar 8, 2018 | Before the open | -0.33 | -0.43 | -30.3% |